Nice

News

Roche calls for talks after NICE rejects drug for progressiv...

Roche has said it will continue with talks with UK health officials to bring its multiple sclerosis drug Ocrevus to NHS patients with primary progressive disease, after NICE said it was not

News

NICE backs funding for Kyowa Kirin's bone disorder drug

Children in England and Wales with a rare inherited disorder causing soft and weak bones can have access to a new therapy after NICE said Kyowa Kirin’s Crysvita can receive regular NHS fund

News

Janssen J&J Johnson and Johnson pharmaceutical companies

NHS lifted Imbruvica restrictions after press campaign

England’s National Health Service has lifted restrictions on Janssen’s blood cancer drug Imbruvica (ibrutinib), after a journalist who was suffering from chronic lymphocytic leukaemia (CLL)

News